Rx Safes, manufacturer of fingerprint recognition home prescription lockboxes, on Thursday announced that it is waging a new war on drugs to reduce prescription drug abuse, backed by a national media campaign.
Canada's Premiers gathered in Charlottetown for the latest Council of the Federation meeting starting on Aug. 26, and health reform is a key topic. The pharmacy community is urging provinces to consider further expanding pharmacists' role as they can make important contributions to improving patient outcomes, reducing costs and ensuring the sustainability of the health care system.
The International Society for Pharmaceutical Engineering on Wednesday announced that it has released a preview of its Drug Shortages Prevention Plan aimed at helping the pharmaceutical industry avoid drug shortages and maintain a reliable supply of medications.
Canadian pharmaceutical company Apotex announced the appointment of Dr. Jeremy Desai to president and CEO. He has spent close to 30 years in a number of senior roles within the pharmaceutical industry and has been with Apotex for the last 11 years.
A new report is shining a light on a key role pharmacists can play in helping patients understand the medicine they’re taking.
Fera Pharmaceuticals on Monday announced that it was selected by Pragma Pharmaceuticals to launch amoxicillin extended-release tablets
With the National Association of Chain Drug Stores Total Store Expo currently underway in Boston, the Boston Globe published an op-ed in its opinion section, Podium, which was co-authored by Steven Anderson, president and CEO of NACDS and Michael Malloy, PharmD and dean of the MCPHS University School of Pharmacy - Worcester/Manchester.
Mylan on Friday announced the launch of potassium chloride extended-release tablets USP in 600-mg and 750-mg dosage strengths.
The Drug Enforcement Administration issued a final rule rescheduling hydrocodone combination products from schedule III to schedule II of the Controlled Substances Act.
Restricting access to samples of generic biological drugs would lead to nearly $140 million in lost savings for every $1 billion in biologics sales, Matrix Global Advisors said.